SOPHiA GENETICS SASOPHEarnings & Financial Report
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions.
Revenue
$15.8K
Gross Profit
$12.3M
Operating Profit
$-18.5M
Net Profit
$-22.4M
Gross Margin
77618.9%
Operating Margin
-116978.7%
Net Margin
-141789.0%
YoY Growth
N/A
EPS
$-0.33
SOPHiA GENETICS SA Q2 FY2025 Financial Summary
SOPHiA GENETICS SA reported revenue of $15.8K for Q2 FY2025, with a net profit of $-22.4M (down 47.5% YoY) (-141789.0% margin). Cost of goods sold was $-12.3M, operating expenses totaled $30.8M.
Key Financial Metrics
| Total Revenue | $15.8K |
|---|---|
| Net Profit | $-22.4M |
| Gross Margin | N/A |
| Operating Margin | -116978.7% |
| Report Period | Q2 FY2025 |
SOPHiA GENETICS SA Quarterly Revenue & Net Profit History
SOPHiA GENETICS SA results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $47.4K | — | N/A | N/A |
| Q2 FY2025 | $15.8K | — | $-22.4M | -141789.0% |
| Q1 FY2025 | $15.8K | — | N/A | N/A |
| Q3 FY2024 | $45.3K | — | N/A | N/A |
| Q2 FY2024 | $29.0K | — | $-15.2M | -52353.5% |
| Q1 FY2024 | $14.0K | — | N/A | N/A |
| Q3 FY2023 | $34.2K | — | N/A | N/A |
| Q2 FY2023 | $22.5K | — | $-21.4M | -94975.1% |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22528 | $34176 | $13966 | $29020 | $45323 | $15779 | $15808 | $47440 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $223.2M | $243838 | $206156 | $181.1M | $206156 | $155309 | $177.6M | $155309 |
| Liabilities | $51.5M | $43708 | $54714 | $59.7M | $54714 | $58819 | $100.9M | $58819 |
| Equity | $171.7M | $200130 | $132.2M | $121.4M | $151442 | $85.6M | $76.7M | $96490 |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-37033 | $-60121 | $-15658 | $-26675 | $-39872 | $-14644 | $-33455 |